Welcome to Perhimpunan Onkologi Radiasi Indonesia


SEAROG-ESTRO School 2017 “Multidisciplinary Management of Head and Neck Oncology”

Multidisciplinary Management of Head and Neck Oncology
10-13 November 2017, Singapore

LEARNING OUTCOMES

By the end of this course participants should be able to:

  • Understand the evolving concepts of head and neck epidemiology and tumour biology, with special focus on squamous cell histotype. Rare histotypes will also be included.
  • Interpret complex head and neck imaging for the purpose of treatment decision making and therapy
  • Make judgements regarding multidisciplinary reasoning and management of tumours in the light of alternative and sometime competing treatment options including surgery and the role of systemic and targeted therapies
  • Make judgments on the availability of evidence for treatment recommendations
  • Understand the challenges of supportive care
  • Understand the principles and practice of modern radiotherapy.

 

COURSE CONTENT

  • Anatomy (clinical and radiologic aspects) incidence, pathology, risk factors (including HPV) of head and neck tumours
  • Clinical work-up for oral cavity and pharyngo-laryngeal tumours, staging and follow up
  • “Organ preservation” approach
  • Rationale for unconventional radiotherapy fractionation, hypoxic sensitisers, concomitant chemo, EGFR inhibitors and new targeted agents
  • Management of oral cavity tumours: medical oncology, surgery and radiotherapy (including brachytherapy)
  • Management of nasopharyngeal carcinoma
  • Management of oropharyngeal tumours: medical oncology, surgery and radiotherapy (including brachytherapy)
  • Management of hypopharyngeal and laryngeal tumours: surgery, radiotherapy and medical oncology chemotherapy approach
  • Management of nasal cavity and para-nasal sinus tumours: surgery, radiotherapy and medical oncology chemotherapy approach
  • Management of the neck nodes
  • Concepts behind selection and delineation of target volumes in radiotherapy
  • Morbidity (acute and late) of treatment
  • Supportive care during and after treatment
  • Metastatic disease
  • Management of recurrent tumours
  • Second primary tumours.

Leave a Reply

Your email address will not be published. Required fields are marked *


Warning: Unknown: write failed: Disk quota exceeded (122) in Unknown on line 0

Warning: Unknown: Failed to write session data (files). Please verify that the current setting of session.save_path is correct (/tmp) in Unknown on line 0